The Rutgers School of Public Health and Rutgers Cancer Institute of New Jersey have welcomed nationally recognized biostatistician Hao Liu, PhD. Dr. Liu will serve as Professor in the Department of Biostatistics and Epidemiology at Rutgers School of Public Health, Director of the Biostatistics Shared Resource, and a resident researcher at Rutgers Cancer Institute.
Hao Liu, PhD
Dr. Liu brings more than 15 years of experience in biostatistics, cancer research, and leadership to Rutgers. He has dedicated his career to cancer exploration using state-of-the-art statistics methods in survival analysis, early-phase clinical trials, and statistical methods for population-based studies. An integral part of numerous cancer center support grant applications, Dr. Liu has participated in building the biostatistics programs in two National Cancer Institute (NCI) cancer centers. During his tenure, both centers achieved the prestigious NCI comprehensive cancer center status.
“I am excited and honored to join the Department of Biostatistics and Epidemiology at Rutgers School of Public Health and take on the leadership of the Biostatistics Shared Resource at Rutgers Cancer Institute,” said Dr. Liu. “It is an incredible opportunity to be able to work with world-class researchers at Rutgers and Rutgers Cancer Institute, the state’s only NCI-designated comprehensive cancer center.”
Dr. Liu joins the Rutgers School of Public Health from Indiana University School of Medicine and Fairbanks School of Public Health, where he was a tenured Professor in the Department of Biostatistics and Health Data Science and Director of the Biostatistics and Data Management Core at Indiana University Simon Comprehensive Cancer Center. Dr. Liu received his PhD in biostatistics from the University of Washington. He also holds a master’s degree in biostatistics from the University of California at Berkeley.
The author of more than 120 peer-reviewed publications, Dr. Liu has been continually funded by National Institutes of Health grants and currently serves on the editorial board of the Journal of the National Cancer Institute.